¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"malignant cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
ciliated cell
¼¶¸ð¼¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, Åõ¸í¼¼Æ÷±Ø¼¼Æ÷Á¾
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾, Åõ¸í¼¼Æ÷¼±¾ÏÁ¾
clear cell carcinoma
Åõ¸í¼¼Æ÷¾ÏÁ¾
clear cell hidradenoma
Åõ¸í¼¼Æ÷¶¡»ùÁ¾
clear cell sarcoma
Åõ¸í¼¼Æ÷À°Á¾
columnar cell
¿øÁÖ¼¼Æ÷
committed cell
¾ô¸Ç¼¼Æ÷, ¼öÀÓ¼¼Æ÷
complex cell
º¹ÇÕ¼¼Æ÷
cone cell
¿ø»Ô¼¼Æ÷
cone cell layer
¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
connective tissue cell
°áÇÕÁ¶Á÷¼¼Æ÷
continuous cell line
¹«ÇÑÁõ½Ä¼¼Æ÷ÁÖ, ¿¬¼Ó°è´ë¼¼Æ÷ÁÖ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
10
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
transitional cell
ÀÌÇ༼Æ÷
transitional cell carcinoma
ÀÌÇ༼Æ÷¾ÏÁ¾
cell line
¼¼Æ÷ÁÖ
giant cell pneumonia
°Å´ë¼¼Æ÷Æó·Å
giant cell tumor
°Å´ë¼¼Æ÷Á¾
granular cell tumor
°ú¸³¼¼Æ÷Á¾¾ç
granulosa cell tumor
°ú¸³Ãþ¼¼Æ÷Á¾¾ç
sickle cell trait
³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
packed cell volume
ÃæÀü¼¼Æ÷¿ëÀû, ³óÃ༼Æ÷¿ëÀû
red cell distribution width
ÀûÇ÷±¸ºÐÆ÷Æø
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
basosquamous cell carcinoma
¹Ù´ÚÆíÆò¼¼Æ÷¾ÏÁ¾, ±âÀúÆíÆò¼¼Æ÷¾ÏÁ¾
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
cell bank
¼¼Æ÷ÀºÇà
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
RBC=£¾red blood cell
ÀûÇ÷±¸.
RDW=> red cell distribution width
ÀûÇ÷±¸ºÐÆ÷Æø
Raji cell assay
¶óÁö¼¼Æ÷½ÃÇè
Reed-Sterberg cell
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
Schwann cell tumor
½´¹Ý¼¼Æ÷Á¾¾ç
Schwann s cell
½´¹Ý¼¼Æ÷.
Sertoli cell
½áÅ丮 ¼¼Æ÷
Sertoli cell only syndrome
½áÅ丮 ¼¼Æ÷ ÁõÈıº
Sezary cell
¼¼ÀÚ¸®¼¼Æ÷
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell cooperation
T¼¼Æ÷Çùµ¿
T cell deficiency
T¼¼Æ÷°áÇÌ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
malignant lymphoma
¾Ç¼º¸²ÇÁÁ¾(¡ðþ)
malignant lymphoma
¾Ç¼º¸²ÇÁÁ¾(?Ì¡).
malignant lymphoproliferative disorder
¾Ç¼º ¸²ÇÁ¼¼Æ÷Áõ½Ä¼º Áúȯ
malignant malaria
¾Ç¼º¸»¶ó¸®¾Æ.
malignant malnutrition
¾Ç¼º¿µ¾ç½ÇÁ¶(Áõ)(¡ç½å×ã÷ðàñø).
malignant melanoma
¾Ç¼ºÈæ»öÁ¾(¡ýÙßäðþ).
malignant melanoma
¾Ç¼ºÈæ»öÁ¾(¡ýÙßäðþ)
malignant melanoma
¾Ç¼ºÈæ»öÁ¾
malignant melanoma
¾Ç¼º Èæ»öÁ¾
malignant myopia=>degenerative myopia
¾Ç¼º±Ù½Ã(¡ÐÎãÊ).
malignant neoplasm
¾Ç¼º½Å»ý¹°(¡ãæßæÚª).
malignant neoplasm
¾Ç¼º½Å»ý¹°(¡ãæßæÚª)
malignant nephrosclerosis
¾Ç¼º½Å°æÈÁõ(ç÷àõãìÌãûùñø).
malignant nephrosclerosis
¾Ç¼º½Å°æÈÁõ(ç÷àõãìÌãûùñø)
malignant neutropenia
¾Ç¼ºÈ£Áß±¸°¨¼ÒÁõ(¡û¿ñéϹÊõá´ñø).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½